Advances in Pathogenesis and Treatment of Infectious Diseases
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Microbiology in Human Health and Disease".
Deadline for manuscript submissions: 31 August 2026 | Viewed by 1428
Special Issue Editor
Interests: HIV; infectious disease epidemiology; tuberculosis; infectious disease control and prevention; tropical diseases
Special Issue Information
Dear Colleagues,
Infectious diseases remain a significant global health challenge, exacerbated by increasing antimicrobial resistance, biofilm-associated infections, and emerging pathogens. Recent advances in molecular diagnostics, phage therapy, and recombinant antibody technologies offer promising new strategies for targeted interventions. However, substantial gaps persist in translating these innovations into clinical practice, particularly regarding polymicrobial infections, the optimization of host-directed tolerance mechanisms, and the reduction of diagnostic delays.
This Special Issue invites submissions that address the pathogenesis of bacterial, viral, and fungal infections, as well as novel therapeutic approaches and innovative diagnostic tools. Contributions focused on antimicrobial stewardship, microbiome engineering, and interdisciplinary strategies to overcome resistance and enhance patient outcomes are especially encouraged. Original research articles, comprehensive reviews, and clinical trials advancing our understanding of infection dynamics and therapeutic frontiers are all welcome.
Join us in shaping the future of infectious disease management by contributing to this critical scientific discourse.
Dr. Francesca Gioia
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- antimicrobial resistance
- phage therapy
- host–pathogen interactions
- molecular diagnostics
- immunotherapy
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
